trial · primary record
Iza-bren
Non-Small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 850 |
| Primary completion | 2031-12-30 |
| Primary endpoint | Progression-Free Survival (PFS) using blinded independent central review (BICR) assessment as defined by Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) |
| Registry ID | NCT07680790 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:47.780Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07680790
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.